MedPath
HSA Approval

APO-DIAZEPAM TABLET 5 mg

SIN00044P

APO-DIAZEPAM TABLET 5 mg

APO-DIAZEPAM TABLET 5 mg

February 24, 1988

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N05BA01

diazepam

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

DIAZEPAM

5 mg

Diazepam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-DIAZEPAM TABLET 5 mg - HSA Approval | MedPath